2014
DOI: 10.1161/circinterventions.114.001607
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous Transcatheter Mitral Valve Replacement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
47
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 143 publications
(48 citation statements)
references
References 44 publications
1
47
0
Order By: Relevance
“…For the most part, evaluation has been limited to animal models or human cadaver study. 91 The percutaneous procedure that has been evaluated the most for the treatment of mitral regurgitation has been the MitraClip procedure. This approach, conceptually derived from the surgical Alfieri or double-orifice technique, uses ≥1 small metallic clips to approximate the edges of mitral leaflets.…”
Section: Percutaneous Mitral Valve Repairmentioning
confidence: 99%
“…For the most part, evaluation has been limited to animal models or human cadaver study. 91 The percutaneous procedure that has been evaluated the most for the treatment of mitral regurgitation has been the MitraClip procedure. This approach, conceptually derived from the surgical Alfieri or double-orifice technique, uses ≥1 small metallic clips to approximate the edges of mitral leaflets.…”
Section: Percutaneous Mitral Valve Repairmentioning
confidence: 99%
“…Transcatheter heart valves for antegrade transseptal and apical delivery are currently being tested in bench and preclinical models. 43 Clinical experience with these devices remains scarce. Although the use of TAVI valves in the mitral position in patients with dysfunctional mitral bioprosthetic valves and annuloplasty rings has shown feasibility and proof of concept, 44,45 there remain many challenges in treating the diseased native MV.…”
Section: Transcatheter Mitral Valve Implantationmentioning
confidence: 99%
“…Because of high prevalence of co-morbidities and associated risk, surgical mitral valve repair or replacement is deferred in a significant percentage of patients (2). For these patients transcatheter repair/replacement are emerging as treatment options (3).…”
Section: Introductionmentioning
confidence: 99%